Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Factors affecting anxiety in multiple sclerosis.
Schwann cells in therapy of spinal cord injuries.
The cuprizone model: regional heterogeneity of pathology.
Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.
Radiologically isolated syndrome - incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review.
The Management of Pediatric Multiple Sclerosis.
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis.
The fraction of varicella zoster virus-specific antibodies among all intrathecally-produced antibodies discriminates between patients with varicella zoster virus reactivation and multiple sclerosis.
Multiple sclerosis fatigue relief by bilateral somatosensory cortex neuromodulation.
Multiple sclerosis and seizures: incidence and prevalence over 40 years.
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.
An assay to quantify species-specific anti-JC virus antibody levels in MS patients.
Insights into TREM2 biology by network analysis of human brain gene expression data.
Multiple Sclerosis and Amyotrophic Lateral Sclerosis: Finding and then Losing an Association.
Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.
Corrigendum.
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS.
Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study.
2-photon imaging of phagocyte-mediated T cell activation in the CNS.
The mechanism of action of interferon-β in relapsing multiple sclerosis.
Fatigue in multiple sclerosis: relationship with disease duration, physical disability, disease pattern, age and sex.
Incidence of multiple sclerosis in multiple racial and ethnic groups.
Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider.
Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials.
Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.

Pages